Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma

Background: Cervical squamous cell carcinoma (CESC) is one of the most common causes of cancer-related death worldwide. N6-methyladenosine (m6A) plays an important role in various cellular responses by regulating mRNA biology. This study aimed to develop and validate an m6A RNA methylation regulator...

Full description

Bibliographic Details
Main Authors:	Jingxin Pan, Lichao Xu, Hongda Pan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-08-01
Series:	Frontiers in Oncology
Subjects:	m6A RNA methylation cervical squamous cell carcinoma prognosis experimental validation
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.01444/full

Similar Items

A Novel Pyroptosis-Related Prognostic Signature for Cervical Squamous Cell Carcinoma
by: Ou T, et al.
Published: (2022-02-01)

Identification of m6a-related signature genes in esophageal squamous cell carcinoma by machine learning method
by: Qi-Xin Shang, et al.
Published: (2023-01-01)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
by: Lichao Xu, et al.
Published: (2020-09-01)

The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma
by: Zhi-Hao Yu, et al.
Published: (2021-07-01)

Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma
by: Chang Gu, et al.
Published: (2021-03-01)

Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration
by: Qin-Qin Jin, et al.
Published: (2023-02-01)

Stratified Prognostic Comparison Between Stage IIB-IVA Cervical Adenocarcinoma and Squamous Cell Carcinoma: A SEER Database-Based Study
by: Guo H, et al.
Published: (2024-04-01)

A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
by: Ruoyan Cao, et al.
Published: (2019-07-01)

Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
by: Wang X, et al.
Published: (2021-11-01)

Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes
by: Miaomiao Liu, et al.
Published: (2022-07-01)

Tumor microenvironment characteristics and prognostic role of m6A modification in lung squamous cell carcinoma
by: Pei Li, et al.
Published: (2024-03-01)

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
by: Fang Wen, et al.
Published: (2021-11-01)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
by: Shuqin Wang, et al.
Published: (2022-06-01)

Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma
by: Jianlin Wang, et al.
Published: (2024-04-01)

Cytological DNA methylation for cervical cancer screening: a validation set
by: Linghua Kong, et al.
Published: (2023-08-01)

LncRNA MAGI2-AS3 is involved in cervical squamous cell carcinoma development through CDK6 up-regulation
by: Qifang Liu, et al.
Published: (2019-11-01)

DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment
by: Hongming Zhu, et al.
Published: (2020-04-01)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
by: Bin Xiao, et al.
Published: (2018-04-01)

m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment
by: Wenyi Zhang, et al.
Published: (2022-04-01)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
by: Zhijing Na, et al.
Published: (2021-08-01)

m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma
by: Junfan Pan, et al.
Published: (2021-06-01)

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
by: Chengquan Shen, et al.
Published: (2021-02-01)

Role of TRPV1 ion channel in cervical squamous cell carcinoma genesis
by: Zhenming Wang, et al.
Published: (2022-08-01)

Identification of the expression patterns and potential prognostic role of m6A-RNA methylation regulators in Wilms Tumor
by: Changlin Jia, et al.
Published: (2023-09-01)

Tumor DNA Methylation Profiles Enable Diagnosis, Prognosis Prediction, and Screening for Cervical Cancer
by: Tu J, et al.
Published: (2022-06-01)

Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
by: Zedong Li, et al.
Published: (2020-03-01)

Recent advances of m6A methylation modification in esophageal squamous cell carcinoma
by: Xiaoqing Zhang, et al.
Published: (2021-08-01)

Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis
by: Caiyun Wu, et al.
Published: (2021-09-01)

Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma
by: Gan Z, et al.
Published: (2019-06-01)

m6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Hongbo Wang, et al.
Published: (2021-02-01)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
by: Saiyan Bian, et al.
Published: (2020-12-01)

Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma
by: Surui Sheng, et al.
Published: (2021-10-01)

Molecular Differences between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic Biomarkers
by: Alma D. Campos-Parra, et al.
Published: (2022-07-01)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
by: Qiang Huang, et al.
Published: (2022-09-01)

Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
by: Yao Feng, et al.
Published: (2023-03-01)

Microinvasive cervical squamous cell carcinoma in Slovenia during the period 2001-2007
by: Gutnik Helena, et al.
Published: (2014-09-01)

Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma
by: Xiaoxu Li, et al.
Published: (2023-02-01)

Knowledge mapping and current trends of m6A methylation in the field of cancer
by: Chunming Zhu, et al.
Published: (2024-02-01)

Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma
by: Yaxin Chen, et al.
Published: (2022-10-01)

Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma
by: Xiu-Shen Li, et al.
Published: (2021-01-01)